Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers — Stella

Home/Amyloidosis, Hereditary/

View on ClinicalTrials.gov

Recruiting

Back to Amyloidosis, Hereditary trials

Trial locations(3 sites)

United States

Columbia University Medical Center, New York, New York

Cleveland Clinic, Cleveland, Ohio

University of Texas Southwestern Medical Center, Dallas, Texas

Key details

Sponsor

University of Texas Southwestern Medical Center

Collaborators

The Cleveland Clinic, Columbia University

Enrollment target

~500 participants

Started

November 2022

Primary completion

June 2027

Age range

30 Years – 80 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.